Business Description
Laboratory Corp of America Holdings
NAICS : 621511
SIC : 8071
ISIN : BRL1CABDR006
Share Class Description:
BSP:L1CA34: BRDRDescription
Laboratory Corp. of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.09 | |||||
| Equity-to-Asset | 0.47 | |||||
| Debt-to-Equity | 0.76 | |||||
| Debt-to-EBITDA | 4.41 | |||||
| Interest Coverage | 5.69 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 2.78 | |||||
| Beneish M-Score | -2.6 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -0.9 | |||||
| 3-Year EBITDA Growth Rate | -21 | |||||
| 3-Year EPS without NRI Growth Rate | -11.3 | |||||
| 3-Year FCF Growth Rate | -17.7 | |||||
| 3-Year Book Growth Rate | -1 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 8.36 | |||||
| Future 3-5Y Total Revenue Growth Rate | 3.8 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 39.24 | |||||
| 9-Day RSI | 40.48 | |||||
| 14-Day RSI | 41.95 | |||||
| 6-1 Month Momentum % | 5.2 | |||||
| 12-1 Month Momentum % | -9.18 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.17 | |||||
| Quick Ratio | 1.02 | |||||
| Cash Ratio | 0.17 | |||||
| Days Inventory | 18.42 | |||||
| Days Sales Outstanding | 56.05 | |||||
| Days Payable | 30.75 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.14 | |||||
| Dividend Payout Ratio | 0.21 | |||||
| Forward Dividend Yield % | 0.98 | |||||
| 5-Year Yield-on-Cost % | 1.15 | |||||
| 3-Year Average Share Buyback Ratio | 4.9 | |||||
| Shareholder Yield % | 1.62 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 27.05 | |||||
| Operating Margin % | 8.81 | |||||
| Net Margin % | 3.24 | |||||
| FCF Margin % | 6.66 | |||||
| ROE % | 4.65 | |||||
| ROA % | 2.28 | |||||
| ROIC % | 4.71 | |||||
| ROC (Joel Greenblatt) % | 18.77 | |||||
| ROCE % | 5 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 43.67 | |||||
| Forward PE Ratio | 13.53 | |||||
| PE Ratio without NRI | 16.16 | |||||
| Shiller PE Ratio | 16.52 | |||||
| Price-to-Owner-Earnings | 110.97 | |||||
| PS Ratio | 1.38 | |||||
| PB Ratio | 2.16 | |||||
| Price-to-Free-Cash-Flow | 20.2 | |||||
| Price-to-Operating-Cash-Flow | 13.31 | |||||
| EV-to-EBIT | 28.98 | |||||
| EV-to-Forward-EBIT | 14.38 | |||||
| EV-to-EBITDA | 16.6 | |||||
| EV-to-Forward-EBITDA | 11 | |||||
| EV-to-Revenue | 1.73 | |||||
| EV-to-Forward-Revenue | 1.77 | |||||
| EV-to-FCF | 25.74 | |||||
| Price-to-Projected-FCF | 0.85 | |||||
| Price-to-Median-PS-Value | 0.99 | |||||
| Earnings Yield (Greenblatt) % | 3.45 | |||||
| FCF Yield % | 5.12 | |||||
| Forward Rate of Return (Yacktman) % | 9.64 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Laboratory Corp of America Holdings Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil R$) | 64,361.421 | ||
| EPS (TTM) (R$) | 5.876 | ||
| Beta | -0.12 | ||
| Volatility % | 18.64 | ||
| 14-Day RSI | 41.95 | ||
| 14-Day ATR (R$) | 1.682155 | ||
| 20-Day SMA (R$) | 265.6995 | ||
| 12-1 Month Momentum % | -9.18 | ||
| 52-Week Range (R$) | 244.57 - 291.94 | ||
| Shares Outstanding (Mil) | 336.5 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Laboratory Corp of America Holdings Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Laboratory Corp of America Holdings Stock Events
| Event | Date | Price(R$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Laboratory Corp of America Holdings Frequently Asked Questions
What is Laboratory Corp of America Holdings(BSP:L1CA34)'s stock price today?
The current price of BSP:L1CA34 is R$261.82. The 52 week high of BSP:L1CA34 is R$291.94 and 52 week low is R$244.57.
When is next earnings date of Laboratory Corp of America Holdings(BSP:L1CA34)?
The next earnings date of Laboratory Corp of America Holdings(BSP:L1CA34) is 2024-04-25.
Does Laboratory Corp of America Holdings(BSP:L1CA34) pay dividends? If so, how much?
The Dividend Yield %  of Laboratory Corp of America Holdings(BSP:L1CA34) is 1.14% (As of Today), Highest Dividend Payout Ratio of Laboratory Corp of America Holdings(BSP:L1CA34) was 0.21. The lowest was 0.16. And the median was 0.19. The  Forward Dividend Yield % of Laboratory Corp of America Holdings(BSP:L1CA34) is 0.98%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers